13/06/19
Quell Therapeutics, founded by Syncona Ltd, appoints Chief Executive
Building a team of leading experts in the field of Regulatory T cell-based therapy and biology London, 13 June 2019 – Quell Therapeutics, a biotechnology company focused on developing engineered T regulatory (Treg) cell therapies, announces the appointment of Iain McGill,…...
Read More